EIDD1931
EIDD1931 is a ribonucleoside analogue associated with NHC, the active form generated from molnupiravir. It is used in antiviral research into RNA-dependent RNA polymerase activity and error-inducing replication mechanisms. Potential risks include cytotoxicity, genotoxicity-related concerns and off-target cellular effects. Only GMP materials will be supplied, logistics all according to GDP.
About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of Action
EIDD1931 is commonly associated with beta-D-N4-hydroxycytidine, also known as NHC, the active ribonucleoside analogue generated from molnupiravir. After intracellular conversion to its triphosphate form, it can be incorporated by viral RNA-dependent RNA polymerases and promote copying errors during RNA replication.
Benefits and Advantages
The compound is relevant for antiviral drug discovery, RNA polymerase research, mutagenesis-based antiviral strategies and comparative evaluation of nucleoside analogue activation. It supports controlled studies on metabolic conversion, antiviral potency and resistance-related mechanisms.
Side Effects and Risks
Potential risks include cytotoxicity, genotoxicity-related concerns, mitochondrial effects and biological activity in rapidly replicating systems. It should be handled as a potent research compound and used only within validated laboratory, pharmaceutical or regulatory development settings.
Professional use only. Supplied exclusively for qualified pharmaceutical, analytical or laboratory environments.
Only GMP materials will be supplied, logistics all according to GDP.
Datasheet
| Molecular Formula | C9H13N3O6 |
|---|---|
| Molecular Weight | 259.22 g/mol |
| CAS Number | 3258-02-4 |
| Storage Condition | Store at -20°C. Keep container tightly closed and protect from moisture and light. |
| Solubility | Solubility depends on solvent and conditions. Please contact us for solvent-specific guidance. |
| Purity | Purity information is available upon request (COA). |
| Synonym | EIDD-1931; EIDD1931; N4-Hydroxycytidine; N-Hydroxycytidine; NHC; beta-D-N4-hydroxycytidine |
| IUPAC/Chemical Name | 4-(hydroxyamino)-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one |
| InChl Key | XCUAIINAJCDIPM-XVFCMESISA-N |
| InChl Code | InChI=1S/C9H13N3O6/c13-3-4-6(14)7(15)8(18-4)12-2-1-5(11-17)10-9(12)16/h1-2,4,6-8,13-15,17H,3H2,(H,10,11,16)/t4-,6-,7-,8-/m1/s1 |
| References | https://pubchem.ncbi.nlm.nih.gov/compound/197020; small-molecule |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.
